<DOC>
	<DOCNO>NCT00565565</DOCNO>
	<brief_summary>This study demonstrate safety tolerability single oral dose BAY60-4552 single dose escalation design . Furthermore , study examines change hemodynamics application test substance.42 hospitalize stable patient chronic heart failure include . Several measurement perform test good drug work wether unwanted reaction drug ( e.g . blood test , ECG , heart rate , blood pressure , adverse event ) . After observation period patient discharge hospital .</brief_summary>
	<brief_title>Single Dose Escalation Study Patients With Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Patients chronic heart failure , undergo routine invasive measurement hemodynamic parameter Acute heart failure acute decompensated heart failure , need acute cardiologic intervention surgery , severe renal hepatic insufficiency , severe valvular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Biventriular chronic heart failure , Pulmonary hypertension</keyword>
</DOC>